


Calla Slimspa Medical Weight Loss Center has served Winter Park, Florida since 2008, offering physician-supervised weight management programs that combine GLP-1 receptor agonist medications with structured nutritional guidance. Under the medical direction of Suzanne Gil, MD, the clinic focuses exclusively on evidence-based weight loss interventions designed to address metabolic dysfunction, appetite dysregulation, and body composition challenges. Patients receive in-person consultations at the Winter Park location, where treatment plans are individualized based on medical history, current health status, and weight loss objectives.
The clinic's pharmacological approach centers on two FDA-approved incretin mimetics: semaglutide and tirzepatide. Semaglutide, a GLP-1 receptor agonist, works by slowing gastric emptying and reducing appetite through central nervous system pathways that regulate satiety. Tirzepatide functions as a dual GLP-1/GIP receptor agonist, offering enhanced glycemic control and weight reduction through complementary mechanisms. Dr. Gil prescribes these medications as part of comprehensive programs that include dosage titration protocols, monitoring for side effects, and adjustments based on patient response. The clinic's approach addresses not only appetite suppression but also the behavioral and nutritional factors that influence long-term body fat reduction and weight maintenance.
Dr. Suzanne Gil brings medical expertise to weight management, evaluating patients for contraindications, comorbid conditions such as type 2 diabetes or hypertension, and individual risk factors that may influence treatment selection. Her clinical model emphasizes patient education on how GLP-1 medications alter hunger signaling and why dietary modifications remain essential even with pharmacological support. The medical team at Calla Slimspa teaches patients to recognize true hunger versus habitual eating patterns, providing practical strategies for maintaining a healthy diet while on medication. This educational component distinguishes the clinic's programs from prescription-only models, as patients learn sustainable habits that support results beyond the active treatment phase.
Patients attending Calla Slimspa in Winter Park can expect structured follow-up visits to track progress toward their goal weight, assess tolerance to medication, and modify treatment protocols as needed. The clinic monitors body composition changes, not just scale weight, to ensure fat loss rather than lean muscle depletion. Office visits include discussions of energy levels, satiety between meals, and any gastrointestinal symptoms common with GLP-1 therapies. The team's focus on teaching healthy dietary patterns means patients receive guidance on macronutrient balance, portion control, and meal timing strategies that complement the appetite-suppressing effects of semaglutide or tirzepatide. This integrated approach addresses both the physiological and behavioral dimensions of weight management.
Calla Slimspa's Winter Park location requires in-person consultations, allowing Dr. Gil to conduct physical examinations, review laboratory results, and establish the physician-patient relationship necessary for controlled medication prescribing. The clinic's longevity since 2008 reflects sustained demand for medically supervised weight loss in the Central Florida region, where the practice has built a reputation for results-oriented programs that combine pharmacotherapy with nutritional accountability. Patients seeking alternatives to surgical weight loss or those who have struggled with diet-and-exercise-only approaches find the clinic's medication-assisted model offers a viable pathway to achieving and maintaining a healthier body weight under ongoing medical supervision.
Suzanne Gil, MD· MD
Topics Mentioned in Reviews
MyPeptideMatch.com is an independent directory. We do not provide medical advice. Always consult a qualified healthcare provider before starting any peptide therapy.


